Test to Diagnose and Distinguish MRSA and MSSA
Topic: MRSA Infections
Author: U.S. Food and Drug Administration - Contact: fda.gov
Published: 2011/05/06 - Updated: 2022/04/07
Contents: Summary - Introduction - Main Item - Related Topics
Synopsis: Blood Culture Test determines whether bacteria growing in a positive blood culture sample are either MRSA or MSSA. The KeyPath MRSA/MSSA Blood Culture Test determines whether bacteria growing in a patient's positive blood culture sample are MRSA or MSSA within about five hours after any bacterial growths are first detected in the sample. Aside from blood culture equipment, the test does not require any specific instruments to get results, which makes it useful in any laboratory. MRSA infections can occur anywhere; however, infections appearing in health care settings are usually more severe and potentially life-threatening given patients being treated in those facilities may have weakened immune systems and frequently undergo procedures such as surgery, which allows an easier spread of bacteria directly into the body.
Introduction
The U.S. Food and Drug Administration has cleared the first test for Staphylococcus aureus (S.aureus) infections that can quickly identify whether the bacteria are methicillin resistant (MRSA) or methicillin susceptible (MSSA).
Main Item
There are many types of Staphylococci bacteria, which cause skin infections, pneumonia, food, and blood infections (blood poisoning). While some S.aureus infections are treated easily with antibiotics, others are resistant (MRSA) to commonly prescribed antibiotics such as penicillin and amoxicillin.
The KeyPath MRSA/MSSA Blood Culture Test determines whether bacteria growing in a patient's positive blood culture sample are MRSA or MSSA within about five hours after any bacterial growths are first detected in the sample. Aside from blood culture equipment, the test does not require any specific instruments to get results, which makes it useful in any laboratory.
"Clearing this test gives health care professionals a test that can confirm S.aureus and then identify whether the bacteria are MRSA or MSSA," said Alberto Gutierrez, Ph.D., director of the Office of In Vitro Diagnostics Device Evaluation and Safety in the FDA's Center for Devices and Radiological Health.
"This not only saves time in diagnosing potentially life-threatening infections, but also allows health care professionals to optimize treatment and start appropriate contact precautions to prevent the spread of the organism."
MRSA infections can occur anywhere; however, infections appearing in health care settings are usually more severe and potentially life-threatening given patients being treated in those facilities may have weakened immune systems and frequently undergo procedures such as surgery, which allows an easier spread of bacteria directly into the body.
The FDA based its clearance on a clinical study of 1,116 blood samples evaluated at four major U.S. hospital centers. Within the organisms determined to be S.aureus, the MRSA determination was 98.9% accurate (178/180) and the MSSA determination was 99.4% accurate (153/154).
The KeyPath MRSA/MSSA Blood Culture Test is manufactured by MicroPhage Inc. of Longmont, Colo.
Explore Related Topics
1 - Antibiotic Produced by Ant Bacteria May Help MRSA Patients - A new antibiotic, produced by bacteria found on a species of African ant, is very potent against antibiotic-resistant superbugs like MRSA.
2 - OSPREY Predicts MRSA Superbugs Counter-moves to New Drugs - With drug-resistant bacteria on the rise common infections like pneumonia or urinary tract infections are harder to treat with standard antibiotics.
3 - New MRSA Superbug Strain Identified in Brazil - New England Journal of Medicine report shows a research team has identified a new superbug that caused bloodstream infection in Brazilian patient.
4 - New Treatment to Cure and Eliminate MRSA Infections - Groundbreaking study by Professor of Biology Kim Lewis to treat and eliminate MRSA superbug a potent bacterium with a resistance to antibiotics.
5 - Drug Resistant MRSA Prevalence in Nursing Homes - Nursing home residents have increased risk factors of MRSA including diabetes, long-term use of devices and inability to perform activities of daily living.
Page Information, Citing and Disclaimer
Disabled World is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.
Cite This Page (APA): U.S. Food and Drug Administration. (2011, May 6 - Last revised: 2022, April 7). Test to Diagnose and Distinguish MRSA and MSSA. Disabled World. Retrieved October 6, 2024 from www.disabled-world.com/health/mrsa/distinguish.php
Permalink: <a href="https://www.disabled-world.com/health/mrsa/distinguish.php">Test to Diagnose and Distinguish MRSA and MSSA</a>: Blood Culture Test determines whether bacteria growing in a positive blood culture sample are either MRSA or MSSA.
Disabled World provides general information only. Materials presented are never meant to substitute for qualified medical care. Any 3rd party offering or advertising does not constitute an endorsement.